CN106999563A - 用于配制酸稳定口服细菌疫苗的方法 - Google Patents

用于配制酸稳定口服细菌疫苗的方法 Download PDF

Info

Publication number
CN106999563A
CN106999563A CN201580067254.8A CN201580067254A CN106999563A CN 106999563 A CN106999563 A CN 106999563A CN 201580067254 A CN201580067254 A CN 201580067254A CN 106999563 A CN106999563 A CN 106999563A
Authority
CN
China
Prior art keywords
rctb
acid
vaccine
oral bacterial
bacterial vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201580067254.8A
Other languages
English (en)
Chinese (zh)
Inventor
尼廷·赛加尔
维布胡·干乍
塔伦·夏尔马
迪帕·西克里瓦尔
尼拉伊·乔希
达温德·吉尔
齐姆拉·伊斯拉埃尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xi Leman Laboratory Private That Mo Shadong And Hui Kang Foundation Is Joint LP
MSD Wellcome Trust Hilleman Laboratories Pvt Ltd
Original Assignee
Xi Leman Laboratory Private That Mo Shadong And Hui Kang Foundation Is Joint LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xi Leman Laboratory Private That Mo Shadong And Hui Kang Foundation Is Joint LP filed Critical Xi Leman Laboratory Private That Mo Shadong And Hui Kang Foundation Is Joint LP
Publication of CN106999563A publication Critical patent/CN106999563A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
CN201580067254.8A 2014-12-31 2015-12-29 用于配制酸稳定口服细菌疫苗的方法 Pending CN106999563A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN4054/DEL/2014 2014-12-31
PCT/IB2015/060022 WO2016108180A2 (en) 2014-12-31 2015-12-29 Process for formulating acid stabilized oral bacterial vaccine
IN4054DE2014 IN2014DE04054A (ko) 2014-12-31 2015-12-29

Publications (1)

Publication Number Publication Date
CN106999563A true CN106999563A (zh) 2017-08-01

Family

ID=56285110

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580067254.8A Pending CN106999563A (zh) 2014-12-31 2015-12-29 用于配制酸稳定口服细菌疫苗的方法

Country Status (6)

Country Link
KR (1) KR20170102253A (ko)
CN (1) CN106999563A (ko)
BR (1) BR112017012102A2 (ko)
IN (1) IN2014DE04054A (ko)
RU (1) RU2017122801A (ko)
WO (1) WO2016108180A2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021005623A1 (en) * 2019-07-08 2021-01-14 Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. A vaccine formulation for protection against enterotoxigenic e. coli (etec) and cholera

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871943A (en) * 1991-02-15 1999-02-16 Uab Research Foundation Immunoassay comprising a truncated pneumococcal surface protein A (PspA)
WO2013148258A1 (en) * 2012-03-29 2013-10-03 Jerome Schentag Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871943A (en) * 1991-02-15 1999-02-16 Uab Research Foundation Immunoassay comprising a truncated pneumococcal surface protein A (PspA)
WO2013148258A1 (en) * 2012-03-29 2013-10-03 Jerome Schentag Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BUNDELL ET AL: "Protection of rats against cholera toxin and cholera-like enterotoxins by immunization with enteric-coated cholera toxin", 《ANNALS OF TROPICAL PAEDIATRICS》 *

Also Published As

Publication number Publication date
IN2014DE04054A (ko) 2016-07-08
RU2017122801A3 (ko) 2018-12-28
KR20170102253A (ko) 2017-09-08
BR112017012102A2 (pt) 2018-01-23
RU2017122801A (ru) 2018-12-28
WO2016108180A2 (en) 2016-07-07
WO2016108180A3 (en) 2016-09-09

Similar Documents

Publication Publication Date Title
AU2018282453B2 (en) Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
Yang et al. Current pathogenic Escherichia coli foodborne outbreak cases and therapy development
Mathipa et al. Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens
Cozens et al. Anti-adhesion methods as novel therapeutics for bacterial infections
Zhao et al. Gastroretentive drug delivery systems for the treatment of Helicobacter pylori
Levine Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine
Graham et al. Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers
Asadpoor et al. Non-digestible oligosaccharides and short chain fatty acids as therapeutic targets against enterotoxin-producing bacteria and their toxins
Yin et al. Microencapsulated phages show prolonged stability in gastrointestinal environments and high therapeutic efficiency to treat Escherichia coli O157: H7 infection
Anand et al. Pathogen-induced secretory diarrhea and its prevention
Isfahani et al. The effect of capsulated and noncapsulated egg-yolk–specific antibody to reduce colonization in the intestine of Salmonella enterica ssp. enterica serovar Infantis–challenged broiler chickens
US10766970B2 (en) Modified carbohydrates, compositions comprising the same, and methods of making and using the same
Grosso et al. Scope and Limitations of Current Antibiotic Therapies against Helicobacter pylori: Reviewing Amoxicillin Gastroretentive Formulations
Adebisi et al. Modification of drug delivery to improve antibiotic targeting to the stomach
Murugaiah The burden of cholera
Lopes et al. Delivery Strategies of Probiotics from Nano-and Microparticles: Trends in the Treatment of Inflammatory Bowel Disease—An Overview
CN106999563A (zh) 用于配制酸稳定口服细菌疫苗的方法
Siddalingam et al. Helicobacter pylori—current therapy and future therapeutic strategies
Edwards et al. Protection of live bacteria from bile acid toxicity using bile acid adsorbing resins
Mulyangote Ethnobotany and bioactivity of medicinal plants used to treat symptoms associated with gastro-intestinal infections in Namibia
Freedman Acute infectious pediatric gastroenteritis: beyond oral rehydration therapy
de Barros et al. Evaluating and optimizing oral formulations of live bacterial vaccines using a gastro-small intestine model
Fernández et al. Evaluation of enteric-coated tablets as a whole cell inactivated vaccine candidate against Vibrio cholerae
Rampedi et al. Leading Paediatric Infectious Diseases—Current Trends, Gaps, and Future Prospects in Oral Pharmacotherapeutic Interventions
Choudhary et al. Probiotic yeasts in human welfare

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170801

WD01 Invention patent application deemed withdrawn after publication